Sagent Makes ‘Aggressive’ Moves In A ‘Challenging’ US Injectables Market
CEO Vishy Chebrol Talks To Generics Bulletin About Strategy Since Nichi Iko Divestment
• By David Wallace
Vishy Chebrol, Sagent’s CEO, answers questions from Generics Bulletin • Source: Shutterstock 
